Pharmafile Logo

Interpharm Consultancy

30 years’ experience of the European pharmaceutical industry in general and 20 years in generics in particular gives Interpharm the background to help you with whatever issues you may be facing. Whether you are thinking about: Business development, Introducing your generic products into Europe, Market intelligence and pricing, Assistance with product licensing (in or out), How to devise an effective defence strategy to protect your brands against generic competition or Bioequivalence studies for your generic developments, please contact us. We can also help with in-house training that is tailored to your company’s individual needs on topics such as understanding the generic market and the legal and IP issues that affect it.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

55 Northiam, Woodside Park, London, N12 7JH, United Kingdom
+44 (0)20 8446 5572

 Latest Content from PMHub 

Is your content good enough to power your multi-channel marketing?

Content shock is the time when increasing volumes of content intersect our limited human capacity to consume it.

The Periodic Table of Pharma Multi-channel Marketing

Our Periodic Table of Pharma Multi-channel Marketing has been designed to provide pharma marketing folk with an at-a-glance overview of all the key elements needed for multi-channel marketing activity.

Could hackers threaten your health?

Increasing cyber threats mean medical device providers must now take security matters more seriously, writes our Say technology blogger.

Hunt vs Hawking: We’ll call it a draw

Who won the recent bout between Jeremy Hunt and Stephen Hawking? We'll let you score the cards.

The changing face of medical communications over the past 15 years

As Porterhouse Medical celebrates its 15 year anniversary, joint MD and founder, Brian Parsons reflects on the changes to the medical communications industry over the past decade and a half.

Indians scalp cowboys in patent war

An unlikely treaty between global pharma and native Americans

Wilmington Healthcare appoints new Account Director

Press Releases | September 26, 2017 | Wilmington Healthcare

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has strengthened its salesforce with the appointment of Gareth Thurston as Account Director.

Perspective on biotech

In this supplementary issue of Perspective, we reveal the emerging technologies taking the biotech world by storm and ask if the definition of a biotech organisation needs updating.

Lucid CEO discusses communication excellence in a multimedia world

“The two words 'information' and 'communication' are often used interchangeably, but they signify quite different things. Information is giving out; communication is getting through,” Sydney J. Harris, a renowned Anglo-American...

What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?

Paul Midgley, Director of NHS Insight at Wilmington Healthcare, explains how pharma should tailor its approach